All In Biotech

Drug Trial Radar · NCT04797832

IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI

Randomized Bilnded Controlled Trial Comparing The Effect of IV Sodium Ferric Gluconate Complex (FERRLECIT R) on Outcome of Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI)

Last checked: Nov 20, 2026Latest source record: Oct 27, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

200

Planned (sponsor's estimate)

Start

Oct 18, 2020

Primary completion

Oct 31, 2024

Study completion Oct 31, 2024

Sponsor

Lead sponsor
Rambam Health Care CampusAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 15, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Iron deficiency is common among patients undergoing TAVI. It is estimated at 54-79%. Previous non-randomized small trial have shown symptomatic benefit in treating iron deficiency in this group of patients. The investigators predict, that as IV iron will improve symptoms, quality of life and exercise tolerance in this group of patients.

Conditions

  • Iron Deficiency Anemia Due to Blood Loss
  • Aortic Stenosis

Interventions

  • IV Sodium Ferric Gluconate ComplexDrug

    125 mg of IV Iron per day to 3 to 5 days according to hospitalisation length.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 6-minute walk change at 1 month.Time frame: 30 days.
  2. 6-minute walk change at one year.Time frame: One year.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rambam Medical Center

    Haifa, Israel · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.